101 related articles for article (PubMed ID: 27476297)
1. THE INFLUENCE OF MONTELUKAST ON THE ACTIVITY OF THE AUTONOMIC NERVOUS SYSTEM ESTIMATED BY HEART RATE VARIABILITY IN EXPERIMENTAL PARTIAL BLADDER OUTLET OBSTRUCTION IN RATS.
Dobrek Ł; Skowron B; Baranowska A; Zurowski D; Thor PJ
Acta Pol Pharm; 2016; 73(3):777-85. PubMed ID: 27476297
[TBL] [Abstract][Full Text] [Related]
2. [Autonomic nervous system estimation by heart rate variability analysis in experimental short and long-lasting bladder outlet obstruction model].
Dobrek Ł; Baranowska A; Skowron B; Thor P
Przegl Lek; 2013; 70(9):719-23. PubMed ID: 24455832
[TBL] [Abstract][Full Text] [Related]
3. The influence of piroxicam, a non-selective cyclooxygenase inhibitor, on autonomic nervous system activity in experimental cyclophosphamide-induced hemorrhagic cystitis and bladder outlet obstruction in rats.
Dobrek Ł; Baranowska A; Skowron B; Thor PJ
Acta Pol Pharm; 2014; 71(3):497-507. PubMed ID: 25265830
[TBL] [Abstract][Full Text] [Related]
4. Heart rate variability after BRL37344, a beta-3 agonist, in experimental bladder outlet obstruction.
Dobrek Ł; Baranowska A; Thor PJ
Postepy Hig Med Dosw (Online); 2013 Aug; 67():848-58. PubMed ID: 24018450
[TBL] [Abstract][Full Text] [Related]
5. The influence of oxazaphosphorines alkylating agents on autonomic nervous system activity in rat experimental cystitis model.
Dobrek Ł; Baranowska A; Thor PJ
Acta Pol Pharm; 2013; 70(6):1097-105. PubMed ID: 24383333
[TBL] [Abstract][Full Text] [Related]
6. Autonomic nervous system activity assessment by heart rate variability in experimental bladder outlet obstruction.
Dobrek Ł; Baranowska A; Skowron B; Thor PJ
Postepy Hig Med Dosw (Online); 2013 Apr; 67():221-8. PubMed ID: 23619221
[TBL] [Abstract][Full Text] [Related]
7. Spectral heart rate variability analysis in experimental obstructive and chemical overactive bladder models.
Dobrek L; Skowron B; Baranowska A; Thor PJ
Adv Clin Exp Med; 2013; 22(3):337-46. PubMed ID: 23828674
[TBL] [Abstract][Full Text] [Related]
8. [Autonomic nervous system activity estimated by heart rate variability in cyclophosphamide-induced overactive bladder experimental model].
Dobrek Ł; Thor P
Pol Merkur Lekarski; 2011 Dec; 31(186):348-52. PubMed ID: 22239004
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin-targeting agents and spectral heart rate variability in experimental partial bladder outlet obstruction in rats.
Dobrek Ł; Baranowska A; Skowron B; Furgała A; Żurowski D; Thor P
Physiol Int; 2016 Mar; 103(1):21-34. PubMed ID: 27030625
[TBL] [Abstract][Full Text] [Related]
10. The ameliorating effect of exogenous melatonin on urinary bladder function in hyperosmolar bladder overactivity and its influence on the autonomic nervous system activity.
Juszczak K; Ziomber A; Machowska A; Furgała A; Dobrek Ł; Wyczółkowski M; Thor PJ
Acta Medica (Hradec Kralove); 2011; 54(2):63-8. PubMed ID: 21842719
[TBL] [Abstract][Full Text] [Related]
11. Spectral heart rate variability in rats with cyclophosphamide-induced hemorrhagic cystitis treated with cyclooxygenase inhibitors.
Dobrek Ł; Baranowska A; Ciesielczyk K; Thor PJ
Folia Med Cracov; 2015; 55(3):57-68. PubMed ID: 26774808
[TBL] [Abstract][Full Text] [Related]
12. The influence of prostaglandin PGE1 and PGF2alpha analogues on autonomic nervous system activity, estimated with heart rate variability, in cyclophosphamide-induced hemorrhagic cystitis in rats.
Dobrek U; Baranowska A; Skowron B; Zurowski D; Furgała A; Thor PJ
Pol Merkur Lekarski; 2014 Dec; 37(222):324-30. PubMed ID: 25715570
[TBL] [Abstract][Full Text] [Related]
13. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
14. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
Sener G; Sehirli O; Toklu H; Ercan F; Alican I
J Pharm Pharmacol; 2007 Jun; 59(6):837-42. PubMed ID: 17637175
[TBL] [Abstract][Full Text] [Related]
15. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
16. Autonomic nervous system activity during bladder filling assessed by heart rate variability analysis in women with idiopathic overactive bladder syndrome or stress urinary incontinence.
Hubeaux K; Deffieux X; Ismael SS; Raibaut P; Amarenco G
J Urol; 2007 Dec; 178(6):2483-7. PubMed ID: 17937953
[TBL] [Abstract][Full Text] [Related]
17. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
19. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
Lee SR; Hong CH; Choi YD; Kim JH
J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
